CPTAC
NCI Launching Fourth Phase of CPTAC With Anticipated $56M in Funding
The reissuance will continue the initiative's focus on proteogenomic research and applying proteogenomics to understanding cancer drug response and resistance.
Multi-Omic Endometrial Cancer Study Reveals Novel Pathways, Treatment Targets
The study characterized aspects of the tumor immune landscape, including immunogenic alterations, neoantigens, and the immune microenvironment.
The 2010s saw major strides made through several large-scale initiatives aimed at mapping the human proteome and developing approaches for clinical work.
A survey asking researchers for their thoughts on the key developments in the field turned up applications ranging from clinical to structural.
Multi-Omic Kidney Cancer Analysis Identifies Subtypes for Stratifying Patients
The researchers combined genomic, transcriptomic, and proteomic profiling to gain insight into the basic biology and possible treatments for the disease.